• Exchange: GreTai Sec M
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Taiwan Liposome Co Ltd

+ Add to Watchlist

4152:TT

192.00 TWD 3.50 1.86%

As of 02:32:14 ET on 10/21/2014.

Snapshot for Taiwan Liposome Co Ltd (4152)

Open: 190.00 Day's Range: 189.00 - 194.50 Volume: 145,002
Previous Close: 188.50 52wk Range: 188.00 - 440.00 1-Yr Rtn: -52.48%

Stock Chart for 4152

No chart data available.
  • 4152:TT 192.00
  • 1D
  • 1M
  • 1Y
188.50
Interactive 4152 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4152

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TWOTCI -
Earnings Per Share (TWD) (ttm) -11.4684
Est. EPS (TWD) (12/2014) -5.9000
Est. PEG Ratio -
Market Cap (M TWD) 10,619.49
Shares Outstanding (M) 55.31
30 Day Average Volume 220,737
Price/Book (mrq) 3.1187
Price/Sale (ttm) 96.7518
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4152

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4152

Taiwan Liposome Company (TLC) is a biopharmaceutical company. The company's line of business includes drug delivery technology, research and development of new drugs. The main products of the company include lipid-based formulation and scale-up for parenteral drugs using micelles and nanoparticles to optimize the pharmacokinetics of drugs.

Hung Chi-LungChairman/CEOYeh Chih-HungPresident
Lin Ju-YunCFO/VP:MgmtTseng Yun-LungVice President:R&D
More Company Profile & Key Executives for 4152

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil